Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership


All
13F
13D/G
Other
Tags
CC transcript
GSK plc (GSK) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/04/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/27/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/31/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/22/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/12/2019 SC 13D GLAXOSMITHKLINE PLC reports a 8.9% stake in MORPHIC HOLDING, INC.
06/07/2019 SC 13D GLAXOSMITHKLINE PLC reports a 10.8% stake in BICYCLE THERAPEUTICS PLC
04/26/2019 SC 13D GLAXOSMITHKLINE PLC reports a 6.7% stake in TURNING POINT THERAPEUTICS, INC.
09/25/2018 SC 13D GLAXOSMITHKLINE PLC reports a 11.7% stake in PRINCIPIA BIOPHARMA INC.
07/05/2018 SC 13D GLAXOSMITHKLINE PLC reports a 8.3% stake in TRANSLATE BIO, INC.
11/16/2017 SC 13D GLAXOSMITHKLINE PLC reports a 13.3% stake in SPERO THERAPEUTICS, INC.
07/10/2017 SC 13D GLAXOSMITHKLINE PLC reports a 9.7% stake in AILERON THERAPEUTICS, INC.
10/28/2016 SC 13D CRISPR Therapeutics AG reports a 8.3% stake in CRISPR THERAPEUTICS AG
02/23/2012 SC 13D ChemoCentryx, Inc. reports a 20.8% stake in CHEMOCENTRYX, INC.
12/09/2010 SC 13D GLAXOSMITHKLINE PLC reports a 19% stake in THERAVANCE, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy